HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George Psaroudakis Selected Research

apixaban

7/2023Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George Psaroudakis Research Topics

Disease

5Neoplasms (Cancer)
05/2024 - 01/2023
5Venous Thromboembolism
05/2024 - 01/2023
5Hemorrhage
05/2024 - 01/2023
1Leukemia
07/2023
1Thrombosis (Thrombus)
04/2023
1Cardiomyopathies (Cardiomyopathy)
01/2023
1Atrial Fibrillation
01/2023

Drug/Important Bio-Agent (IBA)

5RivaroxabanIBA
05/2024 - 01/2023
4Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2024 - 01/2023
2AnticoagulantsIBA
02/2024 - 01/2023
1apixabanIBA
07/2023
1Factor Xa InhibitorsIBA
04/2023

Therapy/Procedure

1Therapeutics
01/2023